4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-24-001949
CVP,Strategy/Corp Development sold 11,000 shares at an average $85.83 ($944,155)
- CVP,Strategy/Corp Development acquired 11,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BOBO DONALD E JR · CVP,Strategy/Corp Development
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +11,000 | $36.75 | $404,250 | 50,502.69 | D |
| 2024-02-13 | Sale : show line 2 in the form 10b5-1 | −470 | $86.35 | $40,582 | 50,032.69 | D |
| 2024-02-13 | Sale : show line 3 in the form 10b5-1 | −10,530 | $85.81 | $903,573 | 39,502.69 | D |
| Open-market sales · 11,000 sh · avg $85.83 · $944,155 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-02-13 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −11,000 | $36.75 | 2024-05-10 | 11,000 | 27,000 | D |
Loading xslF345X05/doc4.xml…